Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer
The companies will work with investigators to share the results with the scientific community
The companies will work with investigators to share the results with the scientific community
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The company will develop and produce premixes for human nutrition applications
AAT is a substantial socio-economic burden to livestock farmers in Sub-Saharan Africa, affecting and killing millions of cattle every year
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Imaginant offers a unique measurement capability through its PELT coating thickness gauges
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Oncodesign Services and ImaginAb sign a Preclinical License and Supply Agreement
Subscribe To Our Newsletter & Stay Updated